U 
Universal Health International Group Holding 2211.HK · HKD
Health Care · HKEX · 🇭🇰 Hong Kong
0.46
-3.16%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥711.5m
FY2015FY2025
Net income
−CN¥26.0m
FY2015FY2025
Free cash flow
−CN¥59.9m
FY2015FY2025
Shareholders' equity
CN¥317.6m
FY2015FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥711.5m | CN¥1.09bn | CN¥1.30bn | CN¥1.27bn | CN¥1.19bn | CN¥1.51bn | CN¥2.42bn | CN¥3.97bn | CN¥3.38bn | CN¥4.81bn |
| Gross profit | CN¥113.4m | CN¥179.9m | CN¥213.8m | CN¥204.2m | CN¥156.9m | CN¥188.5m | CN¥326.8m | CN¥652.1m | CN¥874.1m | CN¥1.34bn |
| Operating income | −CN¥22.6m | −CN¥23.9m | −CN¥86.4m | −CN¥169.7m | −CN¥443.5m | −CN¥502.6m | −CN¥299.8m | −CN¥450.9m | CN¥57.9m | CN¥206.5m |
| Net income | −CN¥26.0m | CN¥413,000 | −CN¥105.4m | −CN¥187.6m | −CN¥675.4m | −CN¥491.4m | −CN¥265.6m | −CN¥917.0m | −CN¥87.8m | CN¥31.2m |
| Diluted earnings per share | -0.32 | 0.01 | -1.81 | -4.27 | -17.48 | -12.74 | -8.57 | -33.66 | -3.91 | 1.57 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥447.6m | CN¥692.9m | CN¥738.9m | CN¥839.1m | CN¥957.8m | CN¥1.50bn | CN¥2.00bn | CN¥2.23bn | CN¥3.30bn | CN¥3.21bn |
| Cash and short-term investments | CN¥13.4m | CN¥36.4m | CN¥43.0m | CN¥57.8m | CN¥33.1m | CN¥131.3m | CN¥628.5m | CN¥929.2m | CN¥1.11bn | CN¥1.33bn |
| Total liabilities | CN¥130.0m | CN¥340.2m | CN¥424.1m | CN¥430.9m | CN¥382.9m | CN¥251.3m | CN¥273.2m | CN¥312.4m | CN¥594.1m | CN¥619.3m |
| Debt | CN¥25.0m | CN¥70.6m | CN¥40.6m | CN¥40.0m | CN¥3.9m | CN¥14.1m | — | — | CN¥154.6m | CN¥166.9m |
| Shareholders' equity | CN¥317.6m | CN¥352.7m | CN¥314.7m | CN¥408.1m | CN¥575.0m | CN¥1.24bn | CN¥1.73bn | CN¥1.92bn | CN¥2.71bn | CN¥2.59bn |
| Shares outstanding | 80m | 67m | 58m | 44m | 39m | 39m | 31m | 27m | 22m | 20m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −CN¥59.8m | −CN¥101.7m | −CN¥18.2m | −CN¥42.4m | −CN¥107.7m | −CN¥408.3m | −CN¥309.2m | −CN¥183.8m | CN¥35.3m | CN¥46.3m |
| Capital spending | −CN¥68,000 | −CN¥17,000 | −CN¥61,000 | −CN¥101,000 | −CN¥1.9m | −CN¥95.7m | −CN¥3.4m | −CN¥111.7m | −CN¥131.1m | −CN¥6.1m |
| Free cash flow | −CN¥59.9m | −CN¥101.8m | −CN¥18.2m | −CN¥42.5m | −CN¥109.6m | −CN¥504.0m | −CN¥312.6m | −CN¥295.5m | −CN¥95.8m | CN¥40.1m |
| Dividends paid | — | — | — | — | — | — | — | — | — | −CN¥74.9m |
Latest quarters
By quarter end
| Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sept 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥270.4m | CN¥441.2m | CN¥497.7m | CN¥591.3m | CN¥500.1m | CN¥250.0m | CN¥797.0m | CN¥398.5m |
| Gross profit | CN¥43.0m | CN¥70.4m | CN¥83.7m | CN¥96.2m | CN¥80.2m | CN¥40.1m | CN¥133.6m | CN¥66.8m |
| Operating income | −CN¥10.7m | −CN¥7.9m | CN¥25.2m | −CN¥21.0m | −CN¥57.0m | −CN¥27.8m | −CN¥31.4m | −CN¥16.0m |
| Net income | −CN¥18.0m | −CN¥8.0m | CN¥21.3m | −CN¥20.9m | −CN¥61.2m | — | −CN¥44.2m | −CN¥22.1m |
| Diluted earnings per share | -0.22 | -0.10 | 0.32 | -0.31 | -1.00 | -0.05 | -0.79 | -0.04 |
| Total assets | CN¥447.6m | CN¥606.1m | CN¥692.9m | CN¥752.1m | CN¥738.9m | — | CN¥861.2m | CN¥861.1m |
| Cash and short-term investments | CN¥13.4m | CN¥50.7m | CN¥36.4m | CN¥35.5m | CN¥43.0m | CN¥43.6m | CN¥60.7m | CN¥60.7m |
| Debt | — | — | CN¥40.3m | — | CN¥40.3m | CN¥40.3m | CN¥42.1m | CN¥42.1m |
| Shareholders' equity | CN¥317.6m | CN¥339.9m | CN¥352.7m | CN¥321.8m | CN¥314.7m | CN¥314.7m | CN¥359.6m | CN¥360.0m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -17.6% | -14.0% | -16.6% |
| Operating income | -49.0% | -46.2% | — |
| Net income | -48.2% | -44.4% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 16.3% | 16.3% | 15.0% | 21.2% |
| Operating margin | -2.6% | -6.9% | -17.7% | -4.1% |
| Net margin | -1.4% | -7.3% | -21.0% | -8.7% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -0.9 | 50.0 | -0.1 | -0.1 | -0.0 | -0.1 | -0.1 | -0.0 | -0.3 | 2.6 |
| Price to sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | 0.0 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 17 Sept 2015.
| FY2015 | FY2014 | |
|---|---|---|
| Paid in the year | 4.70 | 2.80 |
- 10-to-1 reverse split · 30 May 2025
- 10-to-1 reverse split · 14 Dec 2020
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.